Benefits

• Enhanced health management for astronauts.
• Increased mission self-sufficiency for long-duration deep space exploration.
• Reduced weight, size, and cost.
• Supporting the potential for advanced research in zero-gravity conditions.

Technology

OmnigenIQ is developing the first self-contained protein purification and bioreactor system for deployment in a zero-gravity environment. This system synthesises proteins vital to maintaining muscle mass, bone density, and overall cellular function, directly addressing health issues like muscle atrophy and bone loss experienced during long-term space missions.

This self-contained system lessens reliance on resupplies from Earth, increasing mission autonomy for deep space exploration (e.g., missions to Mars), where resupply is impractical. Synthesising proteins and biologicals in situ reduces the need for medical supplies and supplements to be transported from Earth, lowering payload weight and associated costs for space missions.

Potential markets

AUKUS and affiliated space industry partners: Health maintenance and biological production during long-term space flights, missions in low-Earth orbit, and eventual lunar or Mars exploration efforts.

Pharmaceutical: Producing therapeutic proteins, reducing production timelines and costs for biologics, while offering the potential for space-based research to develop novel treatments.

World Health Organisation: Vaccines, therapeutic proteins, and other essential biologics in outbreak areas, providing a rapid, on-the-ground response capability.

Disaster relief: Immediate access to critical biologics and therapeutics, such as clotting factors, insulin, or antibodies, ensuring timely medical interventions in crisis situations.

Veterinary/zoological: Species-specific proteins and vaccines, which can be critical for the health of animals in wildlife reserves or during conservation efforts in remote regions.

Partnering opportunities

OmnigenIQ is excited to partner with the space, engineering, biotech and pharma industry leaders, in addition to companies that can help accelerate development, test in real space environments, and explore commercial and medical applications on Earth and beyond.